Losses shrinking while the business grows: the path to self-funding is visible in the numbers being reported, powered by
The model's full reasoning — Q3 2018 call → NOWe need answer only YES or NO. Need evaluate based on transcript. Company Surmodics. Need determine if management describes still unprofitable or marginally profitable but losses shrinking driven by growth, and treats profitability near. From transcript: Q3 fiscal 2018 revenue $22.2M up 25%. GAAP diluted loss $0.20 per share vs earnings $0.05 prior year. But includes $7.9M IP R&D charge for Embolitech. Non-GAAP EPS $0.27 vs $0.09 prior year. So non-GAAP profitable. GAAP loss due to one-time charge. Company has non-GAAP earnings positive. They revised fiscal 2018 revenue guidance up, non-GAAP EPS $0.39-$0.44 vs prior loss to positive. So on non-GAAP they are profitable. GAAP loss due to acquisition charge. Is company "still unprofitable or only marginally profitable"? GAAP loss but due to one-time IP R&D charge. Underlying business profitable on non-GAAP. They mention operating loss $6.3M due to charge. Excluding charge, operating income? Let's calculate: $7.9M charge, operating loss $6.3M, so excluding charge operating income $1.6M. So underlying operating profit. Revenue growing strongly. They discuss investments. They don't discuss reaching profitability as near because already non-GAAP profitable. The question asks: "On this call, does management describe a company that is STILL UNPROFITABLE OR ONLY MARGINALLY PROFITABLE but whose losses, burn, or shortfall are VISIBLY AND MATERIALLY SHRINKING..." Here management reports non-GAAP EPS $0.27 vs $0.09 prior year, so already profitable on non-GAAP. GAAP loss due to one-time acquisition charge. They don't treat profitability as near because already there. So answer NO. Need be careful: They have GAAP loss but due to one-time IP R&D charge. Management says "strong operating performance" and "non-GAAP earnings". They are not "still unprofitable" in underlying business. So NO. Final answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| MNKD | MannKind Corporation | Q4 2023 | 2024-02-27 | C |
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| QTRX | Quanterix Corporation | Q3 2023 | 2023-11-07 | B |
| ANGO | AngioDynamics, Inc. | Q1 2024 | 2023-10-04 | B |
| SPIR | Spire Global, Inc. | Q1 2023 | 2023-05-10 | B |
| ULCC | Frontier Group Holdings, Inc. | Q1 2023 | 2023-05-07 | C+ |
| TACT | TransAct Technologies Incorporated | Q4 2022 | 2023-03-08 | A |
| TOST | Toast, Inc. | Q4 2022 | 2023-02-16 | C+ |
| OGI | OrganiGram Holdings Inc. | Q3 2022 | 2022-07-14 | B+ |
| IRTC | iRhythm Technologies, Inc. | Q1 2022 | 2022-05-07 | C+ |
| AMC | AMC Entertainment Holdings, Inc. | Q2 2021 | 2021-08-09 | D |
| BCOV | Brightcove Inc. | Q1 2018 | 2018-04-26 | B+ |
| WYY | WidePoint Corporation | Q3 2016 | 2016-11-09 | D |
| ARAY | Accuray Incorporated | Q4 2016 | 2016-08-17 | B |
| VRNS | Varonis Systems, Inc. | Q2 2016 | 2016-08-09 | B+ |
BCOV · Q1 2018 → YESThe question is about whether Brightcove on this earnings call fits a specific profile: still unprofitable or only marginally profitable, but losses shrinking due to business growth, and profitability...YES The transcript shows Brightcove is still not comfortably profitable (Q1 non-GAAP operating loss $74k vs $2.6M prior year, full-year guidance crossing from loss to income), with the gap visibly closing in reported results. Growth is the primary driver: revenue $41.
MNKD · Q4 2023 → YESThe question is about whether MannKind Corporation, based on the earnings call transcript, fits this specific description: still unprofitable or only marginally profitable, but losses shrinking due to...
TOST · Q4 2022 → YESThe question is about whether Toast, Inc. from this earnings call fits a specific profile: still unprofitable or only marginally profitable, but losses shrinking visibly due to business growth, and pr...